Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Victor Weigman, Ph.D. | May 18, 2016

Expanding Treatment Options with Genomics-Enabled Immuno-Oncology

Tumor genomic profiling can direct patients to new therapeutic possibilities. Positive responses aside, many patients are left with few treatment options. Download this presentation to learn how genomics can further illuminate the inherently complex tumor microenvironment – with beneficial implications for immuno-oncology strategies and the future of genomic testing for cancer treatment.

Victor Weigman, Ph.D., Director, Translational Genomics

Related Services:
Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Read More